Brind.

Amgen is involved in a settlement with INPRS over drug safety claims, while also acquiring ChemoCentryx Inc. amid FDA scrutiny.

1 report, 1 independent Updated Jul 21

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Amgen Indiana Public Retirement System FDA

How it developed

Newest first. Tap a step to see who reported it.

Jul 29Amgen acquired ChemoCentryx, a company employing Huibin Yue and Pirow Bekker. Amgen is now submitting data to counter claims made by the FDA.Sub-event
Jul 21Amgen settles drug safety claims with INPRS and acquires ChemoCentryx Inc.1 source
- insideindianabusiness.com

Keep exploring

The entities involved

Amgen
American multinational biopharmaceutical company
- Amgen, City of Hope, and the California Community Foundation are involved in a life sciences and bioscience economic summit held in Downtown Los Angeles.Mon 12:08
- Geode Capital Management increased its stake in Amgen stock and filed the disclosure with the SEC.Mon 02:05
Indiana Public Retirement System
pension fund for public employees in Indiana

Nothing else this week.
FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Related events

Coverage

Newest first; wire copies grouped

Jul 21insideindianabusiness.com